Okyo Pharma earnings were -$4.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest OKYO earnings report on Mar 31, 2025 announced Q1 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, OKYO reported annual earnings of -$4.7M, with -72% growth.
Okyo Pharma (NASDAQ: OKYO) reported Q1 2025 earnings per share (EPS) of N/A, up N/A year over year. Total OKYO earnings for the quarter were N/A. In the same quarter last year, Okyo Pharma's earnings per share (EPS) was N/A.
As of the last Okyo Pharma earnings report, Okyo Pharma is currently losing money. Okyo Pharma's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$4.71 million, a 72.03% decrease year over year.
What was OKYO's earnings growth in the past year?
As of Okyo Pharma's earnings date in Q3 2025, Okyo Pharma's earnings has grown year over year. OKYO earnings in the past year totalled -$4.71 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.